Archive
-
Working Paper
Working PaperSetting Pharmaceutical Drug Prices: What the Medicare Negotiators Need to Know About Innovation and Financialization
Sep 2024
Medicare negotiators need to have a deep understanding - both theoretical and empirical - of the learning processes involved in developing a drug to negotiate a price that is fair.
-
Working Paper
Working Paper SeriesChina’s Development Path: Government, Business, and Globalization in an Innovating Economy
Aug 2022
China’s successful technological development path stands in contrast to the corporate financialization model in the United States
-
Working Paper
Working Paper SeriesGovernment as the First Investor in Biopharmaceutical Innovation: Evidence From New Drug Approvals 2010–2019
Sep 2020
Amid debates over costs—and profits—from a coronavirus vaccine, a new study shows that taxpayers have been footing the bill for every new drug approved between 2010 and 2019
-
Working Paper
Working PaperHow “Maximizing Shareholder Value” Minimized the Strategic National Stockpile: The $5.3 Trillion Question for Pandemic Preparedness Raised by the Ventilator Fiasco
Jul 2020
The success of projects for pandemic preparedness and response depends on the strength of government-business collaborations.